Results 221 to 230 of about 209,966 (285)

Large scale plasma proteomic profiles improve prediction of idiopathic pulmonary fibrosis in general population. [PDF]

Respir Res
Zhou R, Li GW, Zhong Q, Li XY, Liu YX, Zheng JZ, Huang HJ, Wu XB.   +7 more
europepmc   +1 more source

Standard pulmonary function tests and respiratory oscillometry patterns in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. [PDF]

BMJ Open Respir Res
Wu JKY, Xu JJ, Numakura T, Ryan CM, McInnis MC, Binnie M, Shapera S, Fisher JH, Hantos Z, Chow CW.   +9 more
europepmc   +1 more source

Cytokine Expression Profiling in Idiopathic Pulmonary Fibrosis: Insights From Integrative Proteomic Analysis. [PDF]

Can Respir J
Shen C, Wang W, Li G, Wei D, Yang X, Jiang C, Sheng Y, Chen Y, Xu J, Ye S, Chen J.   +10 more
europepmc   +1 more source

How Adherence Shapes Persistence in Idiopathic Pulmonary Fibrosis Treatment: A Call for Real-World Insight. [PDF]

Ann Am Thorac Soc
Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S.   +2 more
europepmc   +1 more source

Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survival. [PDF]

iScience
Matson SM, Ngo LT, Sugawara Y, Fernando V, Lugo C, Kaczorowski-Worthley A, Azeem I, Harrison A, Alsup A, Schueddig E, Koestler D, Rekowski MJ, Wolters PJ, Lee JS, Washburn MP, Solomon JJ, Demoruelle MK.   +16 more
europepmc   +1 more source

Acute exacerbation of idiopathic pulmonary fibrosis: application of the diagnostic criteria and the role of respiratory intermediate care unit and mechanical ventilation. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Barbosa JDR, Salgado SMDS, Esteves MPCMNP.   +2 more
europepmc   +1 more source

Evaluation of large language model-generated medical information on idiopathic pulmonary fibrosis. [PDF]

Front Artif Intell
Cherrez-Ojeda I, Frye BC, Hoheisel A, Cortes-Telles A, Robles-Velasco K, Mateos-Toledo HN, Figueiredo RG, Ryerson CJ, Rodas-Valero G, Calderón JC.   +9 more
europepmc   +1 more source

Comparison of the effectiveness of pirfenidone and nintedanib in patients with advanced stage idiopathic pulmonary fibrosis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Degirmenci G, Satici C, Azakli Yazici D, Cetinkaya N, Erdem U, Demirkol B, Erinc A.   +6 more
europepmc   +1 more source